Ascites does not accompany pleural effusion developing under dasatinib therapy in patients with CML-CP
{{output}}
Objectives: Pleural effusion (PE) is the most frequent pulmonary complication of dasatinib, a tyrosine kinase inhibitor (TKI). Concurrent pericardial effusions have been reported in about one-third of the cases. In this study, we... ...
